Global Angioplasty Balloons Market Size By Product Type, By Application, By End-Users, By Geographic Scope and Forecast

Angioplasty Balloons Market Size and Forecast

Angioplasty Balloons Market size was valued at USD 2.05 Billion in 2024 and is projected to reach USD 2.62 Billion by 2031, growing at a CAGR of 3.43% from 2024 to 2031.

Angioplasty balloons are specialized medical devices used in angioplasty, a technique that opens restricted or clogged blood vessels, particularly arteries, to enhance blood flow. The most typical application for angioplasty balloons is to treat coronary artery disease which occurs when the arteries that deliver blood to the heart constrict owing to plaque buildup a mixture of fat, cholesterol, and other chemicals.

Angioplasty balloons are critical medical equipment used to treat coronary artery disease which develops when the blood arteries that feed blood to the heart constrict or get blocked. The most prevalent application for angioplasty balloons is percutaneous transluminal coronary angioplasty (PTCA). This treatment involves inserting a balloon-tipped catheter into a constricted portion of the coronary artery.

The future usage of angioplasty balloons is expected to change dramatically driven by advances in medical technology and a rising emphasis on improving patient outcomes in cardiovascular treatment. Angioplasty balloons which are used to unblock blocked or restricted blood arteries during percutaneous coronary interventions (PCI) are becoming more complex and adapted to individual patient needs.

Global Angioplasty Balloons Market Dynamics

The key market dynamics that are shaping the global angioplasty balloons market include:

Key Market Drivers:

Rising Cardiovascular Disease Incidence: One of the most important drivers of the angioplasty balloons market is the global increase in cardiovascular illnesses (CVDs). Coronary artery disease, heart attacks, and atherosclerosis are on the rise as a result of poor diets, sedentary lifestyles, and an aging population.

Shift towards Minimally Invasive Procedures: In the medical world, there is an increasing demand for minimally invasive procedures, and angioplasty is one of the important treatments that fits this trend. Minimally invasive operations are preferred because they often have shorter recovery times, less pain, and a lower risk of problems than standard open-heart surgeries. Angioplasty which includes threading a balloon-tipped catheter through the blood vessels to the site of the blockage is a less invasive procedure that may often be done under local anesthesia.

Technological Advancements in Balloon Design: Constant improvements in the design and functionality of angioplasty balloons are another important market driver. Drug-coated balloons which deliver medication to assist prevent arteries from constricting again have considerably improved angioplasty outcomes. Furthermore, the development of specialty balloons such as those intended for use in difficult or calcified lesions has increased the number of patients who can benefit from angioplasty.

Key Challenges:

Risk of Balloon Rupture: One of the biggest issues with angioplasty balloons is the possibility of balloon rupture during the treatment. This can happen if the balloon is inflated above its intended pressure limit or if it comes into contact with a very hard or calcified artery plaque. A rupture can result in consequences such as arterial damage, the necessity for additional treatments, and even the danger of a heart attack.

Difficulty Navigating Complex Lesions: Angioplasty balloons must travel through the coronary arteries to reach the source of the obstruction. Complex lesions such as those with substantial curvature, extensive calcification, or tortuous paths might present significant obstacles. In such circumstances, the balloon may struggle to move through or may not inflate evenly resulting in inadequate or inefficient treatment.

Restenosis and Recurrent Blockages: Following an angioplasty operation, there is a danger that the treated artery will become blocked again. This could be due to the creation of scar tissue or the regrowth of plaque at the treatment location. Restenosis is a common problem that requires repeat treatments or extra interventions like stenting.

Key Trends:

Technological Improvements: The angioplasty balloon industry is experiencing tremendous technological improvements, resulting in the creation of highly specialized and effective devices. Drug-coated balloons (DCBs) and cutting-edge materials designed to improve performance are examples of innovations. Drug-coated balloons are intended to deliver medication directly to the artery walls during the process, preventing restenosis, which is the re-narrowing of the artery following therapy. This technology improves patients' long-term results after angioplasty.

Rise in Cardiovascular Illnesses: The increasing frequency of cardiovascular illnesses (CVDs) is driving up demand for angioplasty balloons. CVDs including coronary artery disease and peripheral artery disease are becoming increasingly prevalent as a result of lifestyle factors such as poor food, lack of exercise, and rising obesity rates.

Focus on Less Invasive Procedures: In the medical world, there is a rising demand for less invasive procedures, and angioplasty balloons fit right in with this trend. Minimally invasive procedures provide various advantages over standard surgical methods including quicker recovery times, a lower chance of complications, and less post-operative pain.

Global Angioplasty Balloons Market Regional Analysis

Here is a more detailed regional analysis of the global angioplasty balloons market:

North America:

The high prevalence of cardiovascular disease and an aging population are the primary drivers of the North American angioplasty balloons market. The United States leads the regional market due to its advanced healthcare infrastructure and high healthcare spending. The rising incidence of coronary artery disease (CAD) and peripheral artery disease (PAD), the growing use of less invasive procedures, and technological developments in balloon catheter design are all major drivers of the North American angioplasty balloons market.

According to the Centers for Disease Control and Prevention (CDC), heart disease is still the top cause of death in the United States accounting for approximately one out of every four deaths. In 2020, around 697,000 persons in the United States died of heart disease. According to the American Heart Association, coronary heart disease alone accounted for 382,820 deaths in 2020. These statistics highlight the region's significant cardiovascular disease burden which drives demand for angioplasty procedures and, as a result, angioplasty balloons. Another important aspect driving market expansion is the aging population in North America.

Asia Pacific:

The Asia Pacific angioplasty balloons market is expanding rapidly, with China emerging as the fastest-growing market due to its large population and rising frequency of cardiovascular illnesses. This trend is projected to continue in the next years driven by several major variables. The increased incidence of cardiovascular disorders, notably coronary artery disease (CAD) is the key driving force behind the Asia Pacific angioplasty balloons market. According to the World Health Organization (WHO), cardiovascular illnesses account for 31% of all fatalities worldwide with a large proportion occurring in low- and middle-income nations many of which are located in the Asia Pacific region.

Another key driver is the improvement of healthcare infrastructure and increased healthcare spending in several Asia Pacific countries. For example, the Australian Institute of Health and Welfare stated that healthcare spending in Australia reached AUD 185.4 billion in 2017-18, up 3.9% from the year before. In Japan, the Ministry of Health, Labour, and Welfare stated that national medical care expenditure totaled JPY 43.4 trillion in fiscal year 2018, up 0.8% over the previous year. The increased usage of minimally invasive procedures such as angioplasty is also driving market expansion. The Indian Council of Medical Research (ICMR) reported a considerable increase in the number of cardiac catheterization facilities across India allowing for more angioplasty treatments.

Global Angioplasty Balloons Market: Segmentation Analysis

The Global Angioplasty Balloons Market is segmented based on Product Type, Application, Packaging Type, and Geography.

Angioplasty Balloons Market, By Product Type

Normal Ballons

Cutting Ballons

Drug-Eluting Balloons

Based on the Product Type, the Global Angioplasty Balloons Market is bifurcated into Normal Ballons, Cutting Ballons, and Drug-Eluting Balloons. The drug-eluting balloons (DEBs) segment is expected to dominate the angioplasty balloons market. DEBs are favored due to their ability to deliver anti-proliferative drugs directly to the arterial wall reducing the risk of restenosis (re-narrowing of the artery) after the procedure. This feature is particularly crucial in complex cases where restenosis is a common concern. The growing preference for minimally invasive treatments and improved patient outcomes further drives the demand for DEBs making them the dominant product type in the market.

Angioplasty Balloons Market, By Application

Coronary Angioplasty

Peripheral Angioplasty

Based on the Application, the Global Angioplasty Balloons Market is bifurcated into Coronary Angioplasty and Peripheral Angioplasty. The coronary angioplasty segment is dominant in the global angioplasty balloons market primarily due to the high prevalence of cardiovascular diseases (CVDs) such as coronary artery disease (CAD). Coronary angioplasty, a procedure to open blocked or narrowed coronary arteries is widely used to restore blood flow to the heart making it a critical treatment for patients with CAD.

Angioplasty Balloons Market, By End-Users

Hospitals

Ambulatory Surgical Centers

Catheterization Laboratories

Based on the End-Users, the Global Angioplasty Balloons Market is bifurcated into Hospitals, Ambulatory Surgical Centers, and Catheterization Laboratories. In the global angioplasty balloons market, the hospital segment is dominant. Hospitals are the primary setting for angioplasty procedures due to their advanced infrastructure, availability of specialized medical personnel, and the ability to handle complex cases. Hospitals often have dedicated cardiac care units and catheterization laboratories making them the preferred choice for both emergency and elective angioplasty procedures. Additionally, hospitals typically manage a higher volume of patients including those with severe or complicated cardiovascular conditions that require immediate intervention, further driving the demand for angioplasty balloons.

Angioplasty Balloons Market, By Geography

North America

Europe

Asia Pacific

Rest of the World

Based on Geography, the Global Angioplasty Balloons Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. The North American region dominates the global angioplasty balloons market primarily due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and widespread adoption of minimally invasive procedures. The presence of leading medical device companies and strong support for research and development further bolster the market. Additionally, North America benefits from favorable reimbursement policies and a well-established regulatory environment that facilitates the approval and use of angioplasty balloons.

Key Players

The "Global Angioplasty Balloons Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic, Boston Scientific Corporation, Johnson & Johnson Services, Inc., Abbott, C. R. Bard, Inc., Spectranetics, Terumo Medical Corporation, Cardinal Health, BIOTRONIK, Cook, ENDOCOR GmbH, B. Braun Melsungen AG.